Pharmacogenomics and Personalized Medicine in Neuropsychiatry

Neuron

Volumn 74, Issue 5, 2012, Pages 773-776

  McMahon, Francis J ^a   Insel, Thomas R ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CLOZAPINE; CYTOCHROME P450; HLA B ANTIGEN; IVACAFTOR; LAMOTRIGINE; LITHIUM; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; PHENYTOIN; SERTRALINE; WARFARIN;

BEHAVIOR THERAPY; BIPOLAR DISORDER; COGNITIVE DEFECT; COGNITIVE THERAPY; CYSTIC FIBROSIS; DEPRESSION; DISEASE MARKER; DNA DETERMINATION; DRUG EFFICACY; DRUG RESEARCH; DRUG SAFETY; DRUG SCREENING; DRUG TARGETING; DRUG TOLERABILITY; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC SCREENING; GENETIC VARIABILITY; GENOME ANALYSIS; HUMAN; MEDICAL EDUCATION; MENTAL DISEASE; NEUROPSYCHIATRY; OPTIMAL DRUG DOSE; PERSONALIZED MEDICINE; PHARMACOGENOMICS; POSTTRAUMATIC STRESS DISORDER; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; REMISSION; SCHIZOPHRENIA; SHORT SURVEY; STEVENS JOHNSON SYNDROME; SYMPTOM; TREATMENT RESPONSE;

CYTOCHROME P-450 ENZYME SYSTEM; GENETIC VARIATION; HUMANS; INDIVIDUALIZED MEDICINE; MENTAL DISORDERS; NEUROPSYCHIATRY; PHARMACOGENETICS;

EID: 84861940981     PISSN: 08966273     EISSN: 10974199     Source Type: Journal    
DOI: 10.1016/j.neuron.2012.05.004     Document Type: Short Survey

References (20)

1. Bainbridge M.N., Wiszniewski W., Murdock D.R., Friedman J., Gonzaga-Jauregui C., Newsham I., Reid J.G., Fink J.K., Morgan M.B., Gingras M.C., et al. Sci. Transl. Med. 2011, 3. re3.
2. Binder E.B., Salyakina D., Lichtner P., Wochnik G.M., Ising M., Pütz B., Papiol S., Seaman S., Lucae S., Kohli M.A., et al. Nat. Genet. 2004, 36:1319-1325.
3. Black J.L., O'Kane D.J., Mrazek D.A. Expert Opin. Drug Metab. Toxicol. 2007, 3:21-31.
4. Carlquist J.F., Anderson J.L. Circulation 2011, 124:2554-2559.
5. Chowdhury N.I., Remington G., Kennedy J.L. Curr. Psychiatry Rep. 2011, 13:156-165.
6. Chung W.H., Hung S.I., Hong H.S., Hsih M.S., Yang L.C., Ho H.C., Wu J.Y., Chen Y.T. Nature 2004, 428:486.
7. Toward Precision Medicine: Building a Knowledge Network for Biomedical Research and a New Taxonomy of Disease 2011, Committee on A Framework for Developing a New Taxonomy of Disease, The National Academies Press, Washington, D.C.
8. Genet. Med. 2007, 9:819-825. Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group.
9. Feero W.G., Guttmacher A.E., Collins F.S. N. Engl. J. Med. 2010, 362:2001-2011.
10. Hyman S.E., Fenton W.S. Science 2003, 299:350-351.
11. Khoury M.J., Coates R.J., Evans J.P. Genet. Med. 2010, 12:680-683.
12. MacArthur D.G., Balasubramanian S., Frankish A., Huang N., Morris J., Walter K., Jostins L., Habegger L., Pickrell J.K., Montgomery S.B., et al. Science 2012, 335:823-828. 1000 Genomes Project Consortium.
13. Malhotra D., Sebat J. Cell 2012, 148:1223-1241.
14. McMahon F.J., Buervenich S., Charney D., Lipsky R., Rush A.J., Wilson A.F., Sorant A.J., Papanicolaou G.J., Laje G., Fava M., et al. Am. J. Hum. Genet. 2006, 78:804-814.
15. Munos B. Nat. Rev. Drug Discov. 2009, 8:959-968.
16. Ramsey B.W., Davies J., McElvaney N.G., Tullis E., Bell S.C., Dřevínek P., Griese M., McKone E.F., Wainwright C.E., Konstan M.W., et al. N. Engl. J. Med. 2011, 365:1663-1672. VX08-770-102 Study Group.
17. Rembold C.M. BMJ 1998, 317:307-312.
18. Taylor M.J., Sen S., Bhagwagar Z. Biol. Psychiatry 2010, 68:536-543.
19. Uhr M., Tontsch A., Namendorf C., Ripke S., Lucae S., Ising M., Dose T., Ebinger M., Rosenhagen M., Kohli M., et al. Neuron 2008, 57:203-209.
20. Winner J.G., Goebert D., Matsu C., Mrazek D.A. Acad. Psychiatry 2010, 34:115-118.